Discussion document from the Blood Products Sub-Committee of The Haemophilia Society detailing the sue and production of Factor VIII between 1975 and 1982. Detailing the demand for Factor VIII and the reason for the increase and the need to rely on imported Factor VII for a long time, consideration on comparison between NHS and commercial product discussed (including ethical, price, hepatitis risk). Further discussion on future prospects in Factor VII technology risk and the AIDS risk. Table shows the increase in Factor VIII demand between 1970 and 1983 and the breakdown between NHS and commercial product